FWP
IBRX icon

Firethorn Wealth Partners’s ImmunityBio IBRX Stock Holding History

Firethorn Wealth Partners’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$240K Buy
25,475
+13,219
+108% +$106K 0.08% 175
2026
Q2 		$107K Buy
12,256
+46
+0.4% +$348 0.03% 200
2026
Q1 		$93.7K Buy
+12,210
New +$83.6K 0.03% 188

Other funds holding IBRX

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
DA
Doliver Advisors Houston, Texas $458M AUM 38.24% 1-Year Est. Return
MWM
MFG Wealth Management Indianapolis, Indiana $138M AUM 31.54% 1-Year Est. Return
CFO
Collective Family Office York, Pennsylvania $484M AUM 13.93% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $2.57B AUM 28.13% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $532M AUM 15.78% 1-Year Est. Return
MIC
Meridian Investment Counsel Lafayette, California $431M AUM 32.55% 1-Year Est. Return
CCIA
Cherry Creek Investment Advisors Englewood, Colorado $261M AUM 29.65% 1-Year Est. Return
GWSA
Global Wealth Strategies & Associates Denver, Colorado $546M AUM 14.96% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Firethorn Wealth Partners's IBRX Position: Q3 2026 in Review

Firethorn Wealth Partners increased its ImmunityBio (IBRX) stake by 108% in Q3 2026, buying an estimated $106K and bringing the position to 25,475 shares worth $240K. The position accounts for 0.08% of the portfolio, ranked #175.

Firethorn Wealth Partners first reported a position in IBRX in Q1 2026 and has held it in 3 quarters since. 33 funds tracked by Wall St. Rank hold IBRX as of Q3 2026.

  • Firethorn Wealth Partners held 25,475 shares of ImmunityBio worth $240K as of Q3 2026.
  • Firethorn Wealth Partners bought 13,219 ImmunityBio shares in Q3 2026, an estimated $106K.
  • ImmunityBio made up 0.08% of Firethorn Wealth Partners's portfolio in Q3 2026, its #175 holding.
  • Firethorn Wealth Partners first reported a position in ImmunityBio in Q1 2026 and has held it in 3 quarters since.
  • 33 funds tracked by Wall St. Rank held ImmunityBio as of Q3 2026.

Based on Firethorn Wealth Partners's 13F filing for Q3 2026, filed 14 Oct 2026.